Clinical trial registry record

Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE)

A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Active Not Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated November 23, 2020.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04641013
Last registry update
November 23, 2020
Status
Active Not Recruiting
Phase
Phase not reported
Sponsor
Kirby Institute
Enrollment
446
Countries
Australia
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
446
Population
Not reported
Duration
2017-12-05 to 2027-12-04
Intervention
Comparator
Not reported
Outcomes measured
Proportion of participants with at least one somatic mutation associated with clonal haematopoiesis — 2017-2019; Median and natural log-transformed Interleukin-6 — 2017-2019; Median (IQR) and natural log-transformed C-reactive protein and Cystatin C; D-dimer >0.27 — 2017-2019; Median (IQR) and natural log-transformed Haemoglobin — 2017-2019; Median (IQR) and natural log-transformed White blood cell count, Median (IQR) and natural log-transformed Neutrophil co…; natural log-transformed Mean corpuscular volume — 2017-2019; natural log transformed Red Cell distribution width — 2017-2019; Proportion of participants with diagnosed cardiovascular conditions, any malignancy, haematologic malignancies — 2017-2…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Clonal haematopoiesis · 80%Title contains controlled term: clonal haematopoiesis. Title supplies longevity context: age-related. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

clonal hematopoiesis
Open primary sourceExport JSON